Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

EDIT

Editas Medicine Inc

Jun 18 • 04:00PM ET

2.69

+0.14 5.49 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: NTLA CRSP PRME DTIL RGNX ABEO SLN VYGR MGTX SLDB

| Held by: VTI IWM VXF IWN IBB VTWO VHT SCHA IWC VTWV

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.22	Insider Own	7.50%	Shs Outstand	153.46M	Perf Week	10.25%
Market Cap	412.81M	Forward P/E	-	EPS next Y	-0.95	Insider Trans	-0.20%	Shs Float	141.95M	Perf Month	9.35%
Enterprise Value	361.13M	PEG	-	EPS next Q	-0.27	Inst Own	46.11%	Short Float	10.61%	Perf Quarter	14.47%
Income	-108.95M	P/S	10.67	EPS this Y	44.82%	Inst Trans	0.74%	Short Ratio	7.27	Perf Half Y	7.17%
Sales	38.69M	P/B	59.72	EPS next Y	4.27%	ROA	-52.76%	Short Interest	15.07M	Perf YTD	31.22%
Book/sh	0.05	P/C	3.34	EPS next 5Y	16.74%	ROE	-326.07%	52W High	4.54 -40.71%	Perf Year	14.47%
Cash/sh	0.81	P/FCF	-	EPS past 3/5Y	17.49% 1.84%	ROIC	-175.22%	52W Low	1.66 62.05%	Perf 3Y	-69.50%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	27.15% -14.89%	Gross Margin	90.07%	Volatility	7.58% 10.85%	Perf 5Y	-92.50%
Dividend TTM	-	EV/Sales	9.33	EPS Y/Y TTM	59.82%	Oper. Margin	-230.09%	ATR (14)	0.26	Perf 10Y	-90.94%
Dividend Ex-Date	-	Quick Ratio	3.22	Sales Y/Y TTM	7.97%	Profit Margin	-281.59%	RSI (14)	48.31	Recom	2.17
Dividend Gr. 3/5Y	- -	Current Ratio	3.22	EPS Q/Q	72.14%	SMA20	-4.58%	Beta	2.14	Target Price	5.78
Payout	-	Debt/Eq	16.32	Sales Q/Q	-39.22%	SMA50	-8.70%	Rel Volume	1.58	Prev Close	2.55
Employees	87	LT Debt/Eq	13.10	Earnings	May 05 BMO	SMA200	0.97%	Avg Volume	2.07M	Price	2.69
IPO	Feb 03, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	1.14% -55.58%	Trades		Volume	3,276,901	Change	5.49%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)